GLP-1 Family intermediate
GLP-1 Agonist Combination Therapies
Rationale and evidence for combining GLP-1 receptor agonists with other glucose-lowering medications.
By Encyclopeptide Editorial | 1 min read
GLP-1 combination-therapy metformin SGLT2 diabetes
Evidence-Based Combinations
GLP-1 + Metformin
- Additive HbA1c reduction (1.5-2.0%)
- Well-tolerated, weight neutral to loss
GLP-1 + SGLT2 Inhibitor
- Enhanced glycemic control and weight loss
- May provide additive CV protection
GLP-1 + Basal Insulin
- Fixed-ratio combinations available
- Improved HbA1c with less weight gain
Clinical Decision Making
Choice depends on cardiovascular comorbidities, renal function, weight goals, hypoglycemia risk, and patient preference.
Chemical Identity
| Property | Value |
|---|---|
| Name | GLP-1 Agonist Combination Therapies |
| Category | GLP-1 Family |
Biological Significance
This molecule plays important roles in biological systems and has potential therapeutic applications.
References
- Encyclopeptide Database. “GLP-1 Agonist Combination Therapies” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about GLP-1 Agonist Combination Therapies with interactive quizzes on Wikipept.
Take a Quiz on Wikipept